Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001063

Drug Information
NamePheniramine    
Synonyms2-(alpha-(2-Dimethylaminoethyl)benzyl)pyridine; NSC 47965; KBio3_001600; 3-Phenyl-3-(2-pyridyl)-N,N-dimethylpropylanine; WLN: T6NJ BYR&2N1&1; IDI1_000235; Prestwick0_000059; Pyriton; NCGC00015831-03; 86-21-5; 2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl-; Oprea1_875595; Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-; DivK1c_000235; AB00053521; SPBio_002138; SPBio_001274; Spectrum_001075; KBio2_006691; Lopac0_000981; CHEBI:308661; 2-[.alpha.-[2-(Dimethylamino)ethyl]benzyl]pyridine; Prestwick1_000059; BSPBio_000217; Spectrum5_001028; 2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl- (9CI); Spectrum2_001277; N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine; 2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-; KBio2_001555; 2-(3-Dimethylamino-1-phenylpropyl)pyridine; Prophenpyridamine; D08355; Dimethyl(3-phenyl-3-(2-pyridyl)propyl)amine; 2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-; 3-Phenyl-3-(2-pyridyl)-N,N-dimethylpropylamine; Spectrum3_000760; DB01620; Pheniramine Bimaleate; Feniramina; Trimeton; pheniramine; CHEMBL1193; NSC47965; Dimethyl(3-phenyl-3-(2-pyridyl)propyl)amine; MolPort-002-561-441; CID4761; Pheniraminum [INN-Latin]; 132-20-7 (bimaleate); Tripoton; Spectrum4_000966; UNII-134FM9ZZ6M; BRN 0192445; KBio2_004123; Pheniramine [INN:BAN]; NCGC00162306-01; 1-Phenyl-1-(2-pyridyl)-3-dimethylaminopropane; Metron; Prestwick3_000059; STOCK2S-17773; Prestwick2_000059; Avil; Feniramine; Pheniramine (INN); Pheniraminum; LS-1852; KBioGR_001311; NINDS_000235; Histapyridamine; p-Aminosalicylsaures salz; 5-22-10-00487 (Beilstein Handbook Reference); Feniramina [INN-Spanish]; BPBio1_000239; N,N-Dimethyl-3-phenyl-3-(2-pyridyl)propylamine; Pyridine, 2-[.alpha.-[2-(dimethylamino)ethyl]benzyl]-; BSPBio_002380; Propheniramine; PHENIRAMINE (SEE ALSO PHENIRAMINE MALEATE 132-20-7); KBio1_000235; EINECS 201-656-2; AC1L1IW8; NCI-C60695; KBioSS_001555; 2-[.alpha.-(2-Dimethylaminoethyl)benzyl]pyridine; BRD-A23072235-050-05-2    
Trade NameAvil    
CompanyAventis Pharmaceuticals Inc.    
IndicationHay feverApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntiallergic Agents    
CAS NumberCAS 86-21-5
FormularC16H20N2    
PubChem Compound IDCID 4761.    
PubChem Substance IDSID 100679.    
SuperDrug ATC IDD04AA38;    
SuperDrug CAS ID000086215;    
TargetHistamine H1 receptorAntagonist[2]
Ref 1Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. To Reference
Ref 2Role of central histaminergic system in lorazepam withdrawal syndrome in rats. Pharmacol Biochem Behav. 2001 Apr;68(4):777-82. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543